Biotech

All Articles

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has actually made a late entrance to the radioligand event, spending 100 million euros ($ 11...

F 2G rears $100M for second try to acquire new antifungal to market

.After F2G's very first effort to acquire a brand-new lesson of antifungal to market was actually hi...

Moderna targets $1.1 B in R&ampD investing slices, falls 5 systems among success tensions

.Moderna has pledged to reduce R&ampD costs through $1.1 billion by 2027. The decision to shrink the...

Sanofi's $80M bank on Key dystrophy medication finishes in period 3 fail

.Just four months after Sanofi bet $80 million in beforehand cash on Key Rehabs' losmapimod, the sys...

Oncternal assets sinks 60% amidst layoffs, trial discontinuations

.Cancer cells firm Oncternal Therapeutics is folding all its professional trials and also laying off...

Roche is supporting out chances that its own injectable obesity possibility can inevitably illustrate 25% fat loss in late-stage trial

.Roche is storing out chances that its injectable obesity possibility could ultimately illustrate 25...

Novo Nordisk hails 'remarkable' fat loss lead for dual-acting oral medication in very early test

.Novo Nordisk has actually lifted the lid on a period 1 test of its own dental amylin and also GLP-1...

AbbVie files suit BeiGene over blood stream cancer cells medicine proprietary knowledge

.Simply a handful of short full weeks after succeeding an FDA Fast Track tag for its investigational...

Lilly supplies one-two strike along with 2nd tranche of good records on once a week blood insulin candidate

.Quickly after a positive records decrease for Eli Lilly's efsitora alfa, the Indianapolis-based com...

BridgeBio cuts gene treatment budget as clinical data let down

.BridgeBio Pharma is lowering its gene therapy finances and also drawing back coming from the modali...